Merrimack Pharmaceuticals Initiates Phase 1 Clinical Study of MM-141 in Patients With Advanced Solid Tumors
December 12, 2012 10:30 ET
|
Merrimack Pharmaceuticals
CAMBRIDGE, Mass., Dec. 12, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced enrollment of its first patient in a Phase 1 clinical study of a novel compound for...
Merrimack Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference
December 05, 2012 10:59 ET
|
Merrimack Pharmaceuticals
CAMBRIDGE, Mass., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy, President & CEO, is scheduled to present at the 31st Annual...
Merrimack Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
December 03, 2012 12:52 ET
|
Merrimack Pharmaceuticals
CAMBRIDGE, Mass., Dec. 3, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that William Sullivan, CFO, is scheduled to present at the Oppenheimer 23rd Annual...
Merrimack Pharmaceuticals to Present at the J.P. Morgan SMid Cap Conference
November 19, 2012 13:37 ET
|
Merrimack Pharmaceuticals
CAMBRIDGE, Mass., Nov. 19, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy, President & CEO, is scheduled to present at the J.P. Morgan...
Merrimack Pharmaceuticals Reports Third Quarter 2012 Financial Results
November 14, 2012 08:00 ET
|
Merrimack Pharmaceuticals
Five Novel Therapeutic Candidates Progressing Through Clinical Development, Including One Phase 3 Trial in Second Line Pancreatic Cancer and Four Phase 2 Trials in Multiple Cancer...
Merrimack Pharmaceuticals to Present at Lazard Capital Markets' 9th Annual Healthcare Conference
November 06, 2012 11:34 ET
|
Merrimack Pharmaceuticals
CAMBRIDGE, Mass., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that William Sullivan, Chief Financial Officer, is scheduled to present at the Lazard...
Merrimack Pharmaceuticals Announces Timing of Third Quarter 2012 Investor Conference Call
November 05, 2012 08:00 ET
|
Merrimack Pharmaceuticals
CAMBRIDGE, Mass., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that the company will host its Third Quarter 2012 Investor Conference Call and webcast...
Merrimack Pharmaceuticals to Present Preclinical Data at the 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 31, 2012 16:00 ET
|
Merrimack Pharmaceuticals
CAMBRIDGE, Mass., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) announced today that preclinical data on two novel cancer compounds will be presented at the 24th...
Merrimack Pharmaceuticals to Present at the UBS Global Life Sciences Conference
September 12, 2012 09:56 ET
|
Merrimack Pharmaceuticals
CAMBRIDGE, Mass., Sept. 12, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that William Sullivan, Chief Financial Officer, is scheduled to present at the UBS...
Merrimack Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
September 07, 2012 11:57 ET
|
Merrimack Pharmaceuticals
CAMBRIDGE, Mass., Sept. 7, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy, President and Chief Executive Officer, is scheduled to present at...